About Vivaris, Ltd.
The success of Vivaris, Ltd. is built on the track record of J. Christopher Mizer (President and CEO) and our advisory board members. This collaborative of professionals provides a wealth of industry and investment experience and substantial financial resources.
Vivaris, Ltd. is a successful private equity investment firm based in Cleveland, Ohio. Our investment strategy is based on the acquisition of niche manufacturing, distribution, service, and technology companies with revenues between $5.0 million to $50.0 million. We focus primarily on the medical device, life science, and biotech industries located in the United States. Vivaris, Ltd. is distinctive among other investment firms in that our senior executives have a long track record for delivering sustained profitable growth. Our experience adds value to the businesses we acquire.
J. Christopher Mizer
Chris Mizer is President and Chief Executive Officer of Vivaris, Ltd. He is a former Vice President and Officer of Carleton, McCreary, Holmes & Co., the investment banking division of Key Corp., where he focused on merger, acquisition, and financing projects for Fortune 500 clients and large, private companies. Prior to joining Key Corp., he was a certified public accountant with Ernst & Young. He earned the B.A., B.S., M.B.A., and M.S. degrees from Case Western Reserve University.
In addition to operational value, our proprietary deal flow and assessment process looks beyond the historical financials to the long-term strategic value of a company’s core competencies within the markets that they serve. We seek companies that show the potential to be significant competitors in their industries. Working with the existing management team, wherever possible, we create and execute a strategic vision and operational improvement plan to position the business for success.
Vivaris, Ltd.'s partnership of business professionals possesses both the investment and operational experience to identify and manage a portfolio of companies that provides high-value and shareholder returns on long-term investments.